In contrast, Hönikl et al.'s study demonstrated that high expression of estrogen receptor alpha (Erα) and aromatase in 60 GBM tissue samples was associated with longer survival times, and treatment with high concentrations of estradiol resulted in reduced tumor cell viability [34]. The gene discussed is ESR1; the disease is glioblastoma.